Taro Pharmaceutical Industries Ltd

Change company Symbol lookup

Select an option...

TARO Taro Pharmaceutical Industries Ltd

FREJN Federal Home Loan Mortgage Corp

NXPL NextPlat Corp

$QCF E-MINI NASDAQ COMPOSITE SPOT FIX

CURI CuriosityStream Inc

AXDX Accelerate Diagnostics Inc

MS-I Morgan Stanley

TCRX TScan Therapeutics Inc

TRCK Track Group Inc

NVSGF Nevada Sunrise Metals Corp

Go

Taro Pharmaceutical Industries Ltd. (Taro) is a science-based pharmaceutical company. The Company operates principally through three entities: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries, Taro Pharmaceuticals Inc. (Taro Canada) and Taro U.S.A. The Company markets over 200 pharmaceutical products in over 25 countries. The Company's owned product brands include Rokacet, with generic names, such as acetaminophen, codeine and caffeine; Topicort, with the generic name, desoximetasone; Etopan, with the generic name etodolac, and Ovide, with the generic name, malathion, among others. The Company's other generic products include acetazolamide, adapalene, alclometasone dipropionate, amiodarone hydrochloride, ammonium lactate, augmented betamethasone dipropionate, cetirizine hydrochloride, clobetasol propionate, clomipramine hydrochloride, clorazepate dipotassium, fluorouracil, ketoconazole, metronidazole, mupirocin and warfarin sodium, among others.